Both in Biotechnology
INmune Bio vs Pelthos Therapeutics
Over the past year INMB returned −24.2% and PTHS returned −68.5%; their daily moves had a correlation of 0.13.
INMB −24.2% PTHS −68.5%Growth of $1, one year, split-adjusted
| Metric | INMB | PTHS |
|---|---|---|
| Price | $1.37 | $10.77 |
| Market cap | $42.3M | $42.3M |
| Today | −1.09% | −6.51% |
| 1 month | −29.6% | −47.5% |
| 6 months | −11.4% | −57.7% |
| Year to date | −12.5% | −65.3% |
| 1 year | −25.4% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 76.9% |
| Net margin | — | −150.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 1.0× |
| Net cash | $18.4M | -$45.7M |
| Dividend yield | — | — |
| Volatility (60d) | 64.9% | 140.5% |
| Short % of float | 11.7% | 8.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).